Diatrizoate Meglumine / Diatrizoate Sodium Injection 282 mg Suppliers & Bulk Manufacturers

Available Forms: Injection / OralSolution

Available Strengths: 282 mg

Reference Brands: Gastrografin (USA), Urografin (India),

Category: Contrast Agent

Diatrizoate Meglumine and Diatrizoate Sodium injection is indicated for radiographic examination of segments of the gastrointestinal tract (esophagus, stomach, proximal small intestine, and colon)

Product Description:

Diatrizoate meglumine and diatrizoate sodium injection is an iodinated radiographic contrast agent widely used in diagnostic imaging procedures. It belongs to the class of ionic, high-osmolar contrast media and is designed to enhance the visibility of internal body structures during X-ray and computed tomography (CT) examinations. The presence of iodine in the formulation allows it to absorb X-rays effectively, thereby improving image contrast and helping clinicians obtain clearer and more detailed diagnostic images.

This combination is commonly used for imaging of the gastrointestinal tract, urinary system, and certain vascular studies. It may be administered orally, rectally, or via injection depending on the type of procedure and diagnostic requirement. The dual-salt formulation of diatrizoate meglumine and diatrizoate sodium helps optimize solubility and imaging performance, making it suitable for a wide range of radiographic applications.

Due to its rapid distribution and reliable contrast-enhancing properties, it has been widely used in clinical practice for many years. Although newer low-osmolar and non-ionic contrast agents are increasingly preferred in some settings, this combination remains an important and cost-effective option in many healthcare systems worldwide when used under proper medical supervision.